Clinical Trials Browser

OTHER × ilorasertib × Clear all

NCT02478320 2023-07-17

Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors

Phase 2 Terminated

12 enrolled 11 charts

Neoplasm Metastasis

NCT02540876 2019-04-22

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Phase 1 Completed

Neoplasm Metastasis